141 related articles for article (PubMed ID: 9288859)
1. A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis.
Resbeut M; Marteau P; Cowen D; Richaud P; Bourdin S; Dubois JB; Mere P; N'Guyen TD
Radiother Oncol; 1997 Jul; 44(1):59-63. PubMed ID: 9288859
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis.
Baughan CA; Canney PA; Buchanan RB; Pickering RM
Clin Oncol (R Coll Radiol); 1993; 5(1):19-24. PubMed ID: 8424910
[TBL] [Abstract][Full Text] [Related]
3. Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease.
Thomson AB; Wright JP; Vatn M; Bailey RJ; Rachmilewitz D; Adler M; Wilson-Lynch KA
Aliment Pharmacol Ther; 1995 Dec; 9(6):673-83. PubMed ID: 8824656
[TBL] [Abstract][Full Text] [Related]
4. Medical prevention and treatment of acute and chronic radiation induced enteritis--is there any proven therapy? a short review.
Zimmerer T; Böcker U; Wenz F; Singer MV
Z Gastroenterol; 2008 May; 46(5):441-8. PubMed ID: 18461520
[TBL] [Abstract][Full Text] [Related]
5. Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients.
Jahraus CD; Bettenhausen D; Malik U; Sellitti M; St Clair WH
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1483-7. PubMed ID: 16099600
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of radiation-induced diarrhea by smectite. Results of a double-blind randomized, placebo-controlled multicenter study].
Hombrink J; Fröhlich D; Glatzel M; Krauss A; Thiel HJ; Meier J; Hamann D; Mücke R; Glaser FH; Köst S
Strahlenther Onkol; 2000 Apr; 176(4):173-9. PubMed ID: 10812390
[TBL] [Abstract][Full Text] [Related]
7. [Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy].
Freund U; Schölmerich J; Siems H; Kluge F; Schäfer HE; Wannenmacher M
Strahlenther Onkol; 1987 Oct; 163(10):678-80. PubMed ID: 3313776
[TBL] [Abstract][Full Text] [Related]
8. Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy.
Kiliç D; Egehan I; Ozenirler S; Dursun A
Radiother Oncol; 2000 Nov; 57(2):125-9. PubMed ID: 11054515
[TBL] [Abstract][Full Text] [Related]
9. Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer.
Henriksson R; Franzén L; Littbrand B
J Clin Oncol; 1992 Jun; 10(6):969-75. PubMed ID: 1588377
[TBL] [Abstract][Full Text] [Related]
10. N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy.
Miller RC; Petereit DG; Sloan JA; Liu H; Martenson JA; Bearden JD; Sapiente R; Seeger GR; Mowat RB; Liem B; Iott MJ; Loprinzi CL;
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1168-74. PubMed ID: 27354129
[TBL] [Abstract][Full Text] [Related]
11. [Multicenter double-blind clinical trial comparing sucralfate vs placebo in the prevention of diarrhea secondary to pelvic irradiation].
Valls A; Pestchen I; Prats C; Pera J; Aragón G; Vidarte M; Algara M
Med Clin (Barc); 1999 Nov; 113(18):681-4. PubMed ID: 10650568
[TBL] [Abstract][Full Text] [Related]
12. Effect of inulin and fructo-oligosaccharide on the prevention of acute radiation enteritis in patients with gynecological cancer and impact on quality-of-life: a randomized, double-blind, placebo-controlled trial.
Garcia-Peris P; Velasco C; Hernandez M; Lozano MA; Paron L; de la Cuerda C; Breton I; Camblor M; Guarner F
Eur J Clin Nutr; 2016 Feb; 70(2):170-4. PubMed ID: 26603881
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of sucralfate in the prophylaxis of diarrhea secondary to acute radiation-induced enteritis. Preliminary results of a double-blind randomized trial].
Valls A; Algara M; Domènech M; Lladó A; Ferrer E; Marín S
Med Clin (Barc); 1991 Mar; 96(12):449-52. PubMed ID: 2056783
[TBL] [Abstract][Full Text] [Related]
14. A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation.
Demers M; Dagnault A; Desjardins J
Clin Nutr; 2014 Oct; 33(5):761-7. PubMed ID: 24200199
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral glutamine during abdominal radiotherapy on chronic radiation enteritis: a randomized controlled trial.
Vidal-Casariego A; Calleja-Fernández A; Cano-Rodríguez I; Cordido F; Ballesteros-Pomar MD
Nutrition; 2015 Jan; 31(1):200-4. PubMed ID: 25466666
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study.
Kruis W; Meier E; Schumacher M; Mickisch O; Greinwald R; Mueller R;
Aliment Pharmacol Ther; 2013 Apr; 37(7):680-90. PubMed ID: 23414061
[TBL] [Abstract][Full Text] [Related]
17. Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis.
Munakata A; Yoshida Y; Muto T; Tsuchiya S; Fukushima T; Hiwatashi N; Kobayashi K; Kitano A; Shimoyama T; Inoue M
J Gastroenterol; 1995 Nov; 30 Suppl 8():108-11. PubMed ID: 8563868
[TBL] [Abstract][Full Text] [Related]
18. A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis.
Hawkey CJ; Dube LM; Rountree LV; Linnen PJ; Lancaster JF
Gastroenterology; 1997 Mar; 112(3):718-24. PubMed ID: 9041232
[TBL] [Abstract][Full Text] [Related]
19. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.
Tursi A; Brandimarte G; Elisei W; Picchio M; Forti G; Pianese G; Rodino S; D'Amico T; Sacca N; Portincasa P; Capezzuto E; Lattanzio R; Spadaccini A; Fiorella S; Polimeni F; Polimeni N; Stoppino V; Stoppino G; Giorgetti GM; Aiello F; Danese S
Aliment Pharmacol Ther; 2013 Oct; 38(7):741-51. PubMed ID: 23957734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
